In accordance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Ipca Laboratories has informed that it has enclosed the disclosure of related party transactions of the half year ended March 31, 2021.
The above information is a part of company’s filings submitted to BSE.